🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Amer Assal

Cornell University

ORCID: 0000-0003-4707-9265

Also affiliated with Columbia University Irving Medical Center, Presbyterian Hospital, Weill Cornell Medicine

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report”.

Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report

Blood Advances(2020)10.1182/bloodadvances.2019001266
N/A
0DataRank · unranked
36 citations

Rajneesh Nath, Jan Černý, Hai-Lin Wang, Mei-Jie Zhang, Hisham Abdel‐Azim +80 more

Autologous and allogeneic hematopoietic cell transplantation for diffuse large B-cell lymphoma–type Richter syndrome

Blood Advances(2021)10.1182/bloodadvances.2021004865
N/A
0DataRank · unranked
54 citations

Kwang Woo Ahn, Carlos Litovich, Yue Chen, Amer Assal, Qaiser Bashir +25 more

Allogeneic Transplantation to Treat Therapy-Related Myelodysplastic Syndrome and Acute Myelogenous Leukemia in Adults

Transplantation and Cellular Therapy(2021)10.1016/j.jtct.2021.08.010
N/A
0DataRank · unranked
29 citations

Natalie S. Callander, Aric C. Hall, Mei-Jei Zhang, Khalid Bo-Subait, Hailin Wang +43 more

Gastrointestinal toxicity of high-dose melphalan in autologous hematopoietic stem cell transplantation: identification of risk factors and a benchmark for experimental therapies

Annals of Hematology(2021)10.1007/s00277-020-04378-8
N/A
0DataRank · unranked
27 citations

Sapna Parmar, Miranda Blanco, Elsa M. Delille, Amer Assal, Markus Y. Mapara +2 more

An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysis

Bone Marrow Transplantation(2021)10.1038/s41409-021-01450-3
N/A
0DataRank · unranked
27 citations

Marcos de Lima, Krishna V. Komanduri, Trent Wang, Mei-Jie Zhang, Karen Chen +56 more

Antibiotic Exposure, Not Alloreactivity, Is the Major Driver of Microbiome Changes in Hematopoietic Cell Transplantation

Transplantation and Cellular Therapy(2021)10.1016/j.jtct.2021.12.015
N/A
0DataRank · unranked
23 citations

Heekuk Park, Cristian Taborda, Christian Gordillo, Markus Y. Mapara, Amer Assal +3 more

Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML

Blood Advances(2021)10.1182/bloodadvances.2021004881
N/A
0DataRank · unranked
13 citations

Alexandra Gomez-Arteaga, Rafael Madero‐Marroquin, Mei‐Jie Zhang, Khalid Bo-Subait, J. Ortiz Sánchez +51 more

Correction to: Hematopoietic cell transplantation utilization and outcomes for primary plasma cell leukemia in the current era

Leukemia(2021)10.1038/s41375-021-01233-1
N/A
0DataRank · unranked
1 citations

Sagar S. Patel, Saulius Girnius, Lohith Bachegowda, Raphael Fraser, Omar Dávila +42 more

Association between the choice of the conditioning regimen and outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis

Haematologica(2023)10.3324/haematol.2022.281958
N/A
0DataRank · unranked
33 citations

Soyoung Kim, Noel Estrada‐Merly, Muhammad Bilal Abid, Mahmoud Aljurf, Amer Assal +44 more